Closed · RFA-DD-21-001 · CFDA 93.073 · Discretionary
Study to Explore Early Development (SEED) Follow up Studies
Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.
- $230K-$1.6M
- Award range
- Closed
- Status
- November 10, 2020
- Close date
- 11
- Expected awards
The verdict
Study to Explore Early Development (SEED) Follow up Studies is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $230,000 -- $1,560,000 across 11 expected awards. Future funding cycles may be published under the same CFDA number.
- $230K-$1.6M
- award range
- Closed
- application status
- 11
- expected awards
- 93.073
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Study to Explore Early Development (SEED) Follow up Studies - is cataloged under number RFA-DD-21-001 and tied to CFDA assistance listing 93.073, posted by Centers for Disease Control and Prevention - ERA. Grants.gov currently shows the opportunity as closed, first posted on September 3, 2020 and last updated on October 23, 2020. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is $230,000 -- $1,560,000. The agency has projected $16.4 million in total estimated funding for this announcement. It expects to issue 11 awards. If the agency funds the expected 11 awards from the $16.4 million estimated pool, the average award works out to roughly $1.5 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on November 10, 2020. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
$230,000 -- $1,560,000
Close Date
November 10, 2020
Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Posted
September 3, 2020
Est. Total Funding
$16,370,000
Expected Awards
11
Instrument
Cooperative Agreement
Description
The purpose of this NOFO is to gain knowledge about autism spectrum disorder (ASD), including risk factors for ASD and the expression of ASD, from childhood through early adulthood, and to obtain information that can be used to improve the health and functioning of individuals with ASD as they mature. This will be completed through 1) analysis of existing data and biospecimens from preschool-aged children and their families who participated in the CDC funded study known as the Study to Explore Early Development (SEED), a multi-phase, multi-site, case-control study of children identified at age 2-5 years with ASD, other developmental disabilities (DD), and from the general population (POP); and 2) longitudinal follow-up of and research on previous SEED participants to obtain information through early adulthood on their health and functioning, service use and needs, and the impact of ASD on their families.These activities will be accomplished through five components (A-E):Component A: Enhanced Epidemiologic Research Using Existing SEED Data Follow-up Surveys of Existing SEED ParticipantsTo conduct analyses of existing SEED data and follow-up surveys of participants from SEED Phases 1, 2, and 3 (referred to as SEED 1-3) to:Address current research gaps, and publish findings related to risk factors for ASD and the characteristics and needs of children with ASD; andSupport the implementation of follow-up surveys in collaboration with CDC from an existing list of SEED participants in SEED 1-3.Component B: In-Person Assessment of Intellectual Abilities of SEED Participants To conduct follow-up assessments of intellectual abilities on a subset of children and adolescents (aged ≥ 8 years), who were initially identified as having ASD or another DD in SEED 1-3 and who completed the follow-up surveys implemented through Component A of this NOFO. To be funded for Component B, applicants must apply and be funded for Component A.Component C: Maternal Auto-Antibody Testing To conduct assays of maternal autoantibodies reactive to proteins in the fetal brain using stored SEED 1 and 2 samples and to conduct analyses of the association between these maternal autoantibodies and ASD. To be funded for Component C, applicants must apply and be funded for Component A.Component D: Genetic Analyses To identify analytic priorities for generating and analyzing SEED genetic data; to develop and implement methods for combining existing SEED 1 genetic data and newly generated SEED 2 and 3 genetic data for use by SEED investigators and contribution to data repositories; and to support SEED investigators conducting analyses to increase understanding of the genetic risk factors for ASD and their interaction with environmental risk factors. To be funded for Component D, applicants must apply and be funded for Component A.Component E: Biorepository To maintain a repository of biospecimens previously collected from SEED 1-3 participants. To be funded for Component E, applicants must apply and be funded for Component A.Applicants should clearly indicate the components for which they are applying and should include, at the beginning of the title, the respective component under which the application should be considered (i.e., Component A, B, C, D, and/or E). A separate application is required for each component.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Natalie Darling NDH6@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Centers for Disease Control and Prevention - ERA
US Travelers Health Research, Surveillance, Communication, and Outreach Network
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Occupational Safety and Health Training Project Grants (T03)
Occupational Safety and Health Education and Research Centers (T42)
RFA-PS-18-000
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |